Ivermectin controlled release implants based on poly-D, l -lactide and poly-ε-caprolactone
Authors:
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 46, 101-110
Abstract
No abstract availableKeywords
Funding Information
- TEFARCO INNOVA Consortium
- CEVA VETEM
This publication has 17 references indexed in Scilit:
- Injectable PLA-basedin situforming implants for controlled release of Ivermectin a BCS Class II drug: solvent selection based on physico-chemical characterizationDrug Development and Industrial Pharmacy, 2012
- Ivermectin Mass Drug Administration to Humans Disrupts Malaria Parasite Transmission in Senegalese VillagesThe American Journal of Tropical Medicine and Hygiene, 2011
- Ivermectin, 'Wonder drug' from Japan: the human use perspectiveProceedings of the Japan Academy, Series B, 2011
- The effect of oral anthelmintics on the survivorship and re-feeding frequency of anthropophilic mosquito disease vectorsActa Tropica, 2010
- Effect of Ivermectin onAnopheles gambiaeMosquitoes Fed on Humans: The Potential of Oral Insecticides in Malaria ControlThe Journal of Infectious Diseases, 2010
- Climate and Dirofilaria infection in EuropeVeterinary Parasitology, 2009
- The Pharmacokinetics and Interactions of Ivermectin in Humans—A Mini-reviewThe AAPS Journal, 2008
- The safety-net story about macrocyclic lactone heartworm preventives: A review, an update, and recommendationsVeterinary Parasitology, 2005
- The effect of γ-irradiation on PLGA/PEG microspheres containing ovalbuminJournal of Controlled Release, 2005
- Degradation of poly(lactide-co-glycolide) (PLGA) and poly(l-lactide) (PLLA) by electron beam radiationBiomaterials, 2005